Predictive Model for Thrombus Formation After Transcatheter Valve Replacement.


Journal

Cardiovascular engineering and technology
ISSN: 1869-4098
Titre abrégé: Cardiovasc Eng Technol
Pays: United States
ID NLM: 101531846

Informations de publication

Date de publication:
12 2021
Historique:
received: 12 01 2021
accepted: 09 11 2021
pubmed: 4 12 2021
medline: 1 1 2022
entrez: 3 12 2021
Statut: ppublish

Résumé

Leaflet thrombosis is a significant adverse event after transcatheter aortic valve (TAV) replacement (TAVR). The purpose of our study was to present a semi-empirical, mathematical model that links patient-specific anatomic, valve, and flow parameters to predict likelihood of leaflet thrombosis. The two main energy sources of neo-sinus (NS) washout after TAVR include the jet flow downstream of the TAV and NS geometric change in volume due to the leaflets opening and closing. Both are highly dependent on patient anatomic and hemodynamic factors. As rotation of blood flow is prevalent in both the sinus of Valsalva and then the NS, we adopted the vorticity flux or circulation (Г) as a metric quantifying overall washout. Leaflet thrombus volumes were segmented based on hypo-attenuating leaflet thickening (HALT) in post-TAVR patient's gated computed tomography. Г was assessed using dimensional scaling as well as computational fluid dynamics (CFD) respectively and correlated to the thrombosis volumes using sensitivity and specificity analysis. Г in the NS, that accounted for patient flow and anatomic conditions derived from scaling arguments significantly better predicted the occurrence of leaflet thrombus than CFD derived measures such as stasis volumes or wall shear stress. Given results from the six patient datasets considered herein, a threshold Г value of 28.0 yielded a sensitivity and specificity of 100% where patients with Gamma < 28 developed valve thrombosis. A 10% error in measurements of all variables can bring the sensitivity specificity down to 87%. A predictive model relating likelihood of valve thrombosis using Г in the NS was developed with promising sensitivity and specificity. With further studies and improvements, this predictive technology may lead to alerting physicians on the risk for thrombus formation following TAVR.

Identifiants

pubmed: 34859378
doi: 10.1007/s13239-021-00596-x
pii: 10.1007/s13239-021-00596-x
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

576-588

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL119824
Pays : United States
Organisme : American Heart Association
ID : 19POST34380804

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. Biomedical Engineering Society.

Références

Altisent, O.A.-J., et al. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients. Clin. Res. Cardiol. 105(6):508–517, 2016.
Arora, S., et al. Early transcatheter valve prosthesis degeneration and future ramifications. Cardiovasc. Diagnosis Ther. 7(1):1, 2017.
Athappan, G., et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J. Am. Coll. Cardiol. 63(20):2101–2110, 2014.
pubmed: 24632286 pmcid: 24632286
Chakravarty, T., et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. The Lancet. 389(10087):2383–2392, 2017.
Dangas, G., et al. Bioprosthetic valve thrombosis: insights from transcatheter and surgical implants. Struct. Heart. 4(5):382–388, 2020.
Darwish, A., et al. In vitro characterization of Lagrangian fluid transport downstream of a dysfunctional bileaflet mechanical aortic valve. AIP Adv. 10(9):095319, 2020.
Del Trigo, M., et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J. Am. Coll. Cardiol. 67(6):644–655, 2016.
pubmed: 26868689 pmcid: 26868689
Gorbet, M.B. and M.V. Sefton, Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. The Biomaterials: Silver Jubilee Compendium, 2004: p. 219–241.
Hafiz, A. M., et al. Clinical or symptomatic leaflet thrombosis following transcatheter aortic valve replacement: insights from the US FDA MAUDE database. Struct. Heart. 1(5–6):256–264, 2017.
Hansson, N. C., et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J. Am. Coll. Cardiol. 68(19):2059–2069, 2016.
pubmed: 27580689 pmcid: 27580689
Hatoum, H., et al. Aortic sinus flow stasis likely in valve-in-valve transcatheter aortic valve implantation. J. Thorac. Cardiovasc. Surg. 154(1):32.e1-43.e1, 2017.
Hatoum, H., et al. Implantation depth and rotational orientation effect on valve-in-valve hemodynamics and sinus flow. Ann. Thorac. Surg. 106(1):70–78, 2018.
pubmed: 29501642 pmcid: 29501642
Hatoum, H., et al. Impact of leaflet laceration on transcatheter aortic valve-in-valve washout: BASILICA to solve neosinus and sinus stasis. JACC Cardiovasc. Interv. 12(13):1229–1237, 2019.
pubmed: 31272669 pmcid: 31272669
Hatoum, H., et al. Impact of BASILICA on sinus and neo-sinus hemodynamics after valve-in-valve with and without coronary flow. Cardiovasc. Revasc. Med. 21:271–276, 2019.
pubmed: 31281093 pmcid: 31281093
Hatoum, H., et al. Impact of patient-specific morphologies on sinus flow stasis in transcatheter aortic valve replacement: an in vitro study. J. Thorac. Cardiovasc. Surg. 157(2):540–549, 2019.
pubmed: 29980299 pmcid: 29980299
Hatoum, H., et al. Leaflet laceration to improve neosinus and sinus flow after valve-in-valve. Circul. Cardiovasc. Interv. 12(3):e007739, 2019.
Hatoum, H., et al. Sinus hemodynamics variation with tilted transcatheter aortic valve deployments. Ann. Biomed. Eng. 47(1):75–84, 2019.
pubmed: 30151733 pmcid: 30151733
Hatoum, H., et al. Impact of BASILICA on sinus and neo-sinus hemodynamics after valve-in-valve with and without coronary flow. Cardiovasc. Revasc. Med. 21(3):271–276, 2020.
pubmed: 31281093 pmcid: 31281093
Hatoum, H., and L. P. Dasi. Sinus hemodynamics in representative stenotic native bicuspid and tricuspid aortic valves: an in-vitro study. J. Fluids. 3(3):56, 2018.
Hatoum, H., and L. P. Dasi. Spatiotemporal complexity of the aortic sinus vortex as a function of leaflet calcification. J Ann. Biomed. Eng. 47(4):1116–1128, 2019.
Hatoum, H., B. L. Moore, and L. P. Dasi. On the significance of systolic flow waveform on aortic valve energy loss. Ann. Biomed. Eng. 46(12):2102–2111, 2018.
pubmed: 30030772 pmcid: 30030772
Jabbour, R. J., et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 71(14):1513–1524, 2018.
pubmed: 29622157 pmcid: 29622157
Kapadia, S., E. M. Tuzcu, and L. G. Svensson. Anatomy and flow characteristics of neosinus: important consideration for thrombosis of transcatheter aortic valves. Circulation. 17:1610–1612, 2017.
Karabelas, E., et al. Towards a computational framework for modeling the impact of aortic coarctations upon left ventricular load. J. Front. Physiol. 9:538, 2018.
Kataruka, A., and C. M. Otto. Valve durability after transcatheter aortic valve implantation. J. Thorac. Dis. 10(Suppl 30):S3629, 2018.
pubmed: 30505545 pmcid: 30505545
Khan, J. M., et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human. JACC Cardiovasc. Interv. 11(7):677–689, 2018.
pubmed: 29622147 pmcid: 29622147
Kodali, S. K., et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J. Cardiol. 107(7):1058–1064, 2011.
pubmed: 21419887 pmcid: 21419887
Kundu, P. K., I. Cohen, and D. Dowling. Fluid Mechanics Book, vol, 77. Cambridge: Academic Press, p. 108, 1990.
Langer, N. B., et al. Injuries to the aorta, aortic annulus, and left ventricle during transcatheter aortic valve replacement: management and outcomes. Circul Cardiovasc. Interv. 10(1):e004735, 2017.
Latib, A., et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. J Circul. Cardiovasc. Interv. 8(4):e001779, 2015.
Liang, A., et al. Development of an animal model of blood stasis syndrome and thrombosis. China J. Chin. Mater. Med. 30(20):1613–1616, 2005.
Lowe, G. D. Virchow’s triad revisited: abnormal flow. Pathophysiol. Haemostasis Thromb. 33(5–6):455–457, 2003.
Mack, M. J., et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med. 380(18):1695–1705, 2019.
pubmed: 30883058 pmcid: 30883058
Madukauwa-David, I. D., et al. An evaluation of the influence of coronary flow on transcatheter heart valve neo-sinus flow stasis. Ann. Biomed. Eng. 48(1):169–180, 2020.
pubmed: 31313048 pmcid: 31313048
Madukauwa-David, I. D., et al. Transcatheter aortic valve deployment influences neo-sinus thrombosis risk: an in vitro flow study. J. Catheter. Cardiovasc. Interv. 95(5):1009–1016, 2020.
Makkar, R. R., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366(18):1696–1704, 2012.
pubmed: 22443478 pmcid: 22443478
Makkar, R. R., et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N. Engl. J. Med. 373(21):2015–2024, 2015.
pubmed: 26436963 pmcid: 26436963
Makkar, R. R., et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy. J. Am. Coll. Cardiol. 75(24):3003–3015, 2020.
pubmed: 32553252 pmcid: 32553252
Makkar, R., PARTNER 3 Low-Risk Computed Tomography (CT) Sub-study: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves. J Paper presentation at: Transcatheter Cardiovascular Therapeutics, 2019
De Marchena, E., et al. Thrombus formation following transcatheter aortic valve replacement. JACC Cardiovasc. Interv. 8(5):728–739, 2015.
pubmed: 25946447 pmcid: 25946447
Midha, P. A., et al. Neo-sinus washout is faster in supra-annular transcatheter heart valves. Circulation. 136(suppl_1):A19038, 2017.
Mikell, F., et al. Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis. Circulation. 66(4):755–763, 1982.
pubmed: 7116593 pmcid: 7116593
Mylotte, D., and N. Piazza. Transcatheter aortic valve replacement failure: deja vu ou jamais vu? Circul Cardiovasc Interv. 2015. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002531 .
doi: 10.1161/CIRCINTERVENTIONS.115.002531
Oosterlinck, W., and B. Meuris. Structural Valve Degeneration in bioprosthesis. In: The Inaugural Meeting of the Heart Valve Society, 2015.
Pache, G., et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur. Heart J. 37(28):2263–2271, 2016.
pubmed: 26446193 pmcid: 26446193
Pasic, M., et al. Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention. JACC Cardiovasc. Interv. 8(1A):1–9, 2015.
pubmed: 25616813 pmcid: 25616813
Pibarot, P., et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort-A analysis. J. Am. Coll. Cardiol. 64(13):1323–1334, 2014.
pubmed: 25257633 pmcid: 25257633
Pislaru, S. V., V. T. Nkomo, and G. S. Sandhu. Assessment of prosthetic valve function after TAVR. JACC Cardiovasc Imaging. 9(2):193–206, 2016.
pubmed: 26846938 pmcid: 26846938
Plitman Mayo, R., et al. Numerical models for assessing the risk of leaflet thrombosis post-transcatheter aortic valve-in-valve implantation. Ro. Soc. Open Sci. 7(12):201838, 2020.
Reardon, M. J., et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 376(14):1321–1331, 2017.
pubmed: 28304219 pmcid: 28304219
Rodriguez-Gabella, T., et al. Long-term outcomes following surgical aortic bioprosthesis implantation. J. Am. Coll. Cardiol. 71(13):1401–1412, 2018.
pubmed: 29598859 pmcid: 29598859
Sadrabadi, M. S., et al. Fluid-structure coupled biotransport processes in aortic valve disease. J. Biomech. 117:110239, 2021.
Schirmer, S. H., et al. Thrombosis of TAVI prosthesis—cause for concern or innocent bystander? A comment and review of currently available data. Clin. Res. Cardiol. 106:79–84, 2017.
pubmed: 27995320 pmcid: 27995320
Sellers, S. L., et al. Transcatheter aortic heart valves: histological analysis providing insight to leaflet thickening and structural valve degeneration. JACC Cardiovasc. Imaging. 12(1):135–145, 2019.
pubmed: 30448122 pmcid: 30448122
Sibilitz, K. L., M. Fukutomi, and L. Sondergaard. Valve thrombosis after transcatheter aortic valve replacement—cause for concern? Ann. Cardiothorac. Surg. 6:505–507, 2020.
Singh-Gryzbon, S., et al. Influence of patient-specific characteristics on transcatheter heart valve neo-sinus flow: an in silico study. Ann. Biomed. Eng. 10:2400–2411, 2020.
Sondergaard, L., et al. Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves. Eur Heart J. 38(28):2201–2207, 2017.
pubmed: 28838044 pmcid: 28838044
Spühler, J. H., et al. 3D fluid–structure interaction simulation of aortic valves using a unified continuum ALE FEM model. J. Front. Physiol. 9:363, 2018.
Tay, E. L., et al. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc. Interv. 4(2):228–234, 2011.
pubmed: 21349463 pmcid: 21349463
Trusty, P. M., et al. Neo-sinus flow stasis correlates with thrombus volume in patients post-TAVR. J. Struct. Heart. 3(sup1):120–120, 2019.
Urena, M., et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J. Am. Coll. Cardiol. 60(18):1743–1752, 2012.
Vahidkhah, K., and A. N. Azadani. Supra-annular Valve-in-Valve implantation reduces blood stasis on the transcatheter aortic valve leaflets. J. Biomech. 58:114–122, 2017.
Van Der Boon, R. M., et al. New conduction abnormalities after TAVI—frequency and causes. Nat. Rev. Cardiol. 9(8):454, 2012.
Vasa-Nicotera, M., et al. Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 5(8):858–865, 2012.
pubmed: 22917458 pmcid: 22917458
Yanagisawa, R., et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. JACC Cardiovasc. Imaging. 10(1):1–11, 2017.
Zakerzadeh, R., M.-C. Hsu, and M. S. Sacks. Computational methods for the aortic heart valve and its replacements. J. Expert Rev. Med. Devices. 14(11):849–866, 2017.

Auteurs

Hoda Hatoum (H)

Department of Biomedical Engineering, Georgia Institute of Technology, 387 Technology Circle, Atlanta, GA, 30313, USA.
Department of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA.

Shelly Singh-Gryzbon (S)

Department of Biomedical Engineering, Georgia Institute of Technology, 387 Technology Circle, Atlanta, GA, 30313, USA.
Department of Chemical & Process Engineering, The University of the West Indies, St Augustine, Trinidad and Tobago.

Fateme Esmailie (F)

Department of Biomedical Engineering, Georgia Institute of Technology, 387 Technology Circle, Atlanta, GA, 30313, USA.

Philipp Ruile (P)

Department of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Franz-Josef Neumann (FJ)

Department of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Philipp Blanke (P)

University of British Columbia and St. Paul's Hospital in Vancouver, Vancouver, Canada.

Vinod H Thourani (VH)

Department of Cardiovascular Surgery, Marcus Heart Valve Center, Piedmont Heart Institute, Atlanta, GA, USA.

Ajit P Yoganathan (AP)

Department of Biomedical Engineering, Georgia Institute of Technology, 387 Technology Circle, Atlanta, GA, 30313, USA.

Lakshmi Prasad Dasi (LP)

Department of Biomedical Engineering, Georgia Institute of Technology, 387 Technology Circle, Atlanta, GA, 30313, USA. lakshmi.dasi@gatech.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH